Fundz
Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Selkirk Pharma Appoints Colleen Dixon As Chief Executive Officer

PRIVATEJul 09, 2024almost 2 years ago

Position

Chief Executive Officer

Company

Selkirk Pharma

Colleen Dixon
SpokaneManufacturing

Description

Selkirk Pharma, Inc. has announced the appointment of Colleen Dixon as the company’s new Chief Executive Officer, succeeding Patrick Haffey, the founder of Selkirk Pharma and its Chairman and CEO for the past 6 years. Colleen Dixon’s appointment marks a significant milestone for Selkirk Pharma, reflecting the company's commitment to strategic growth and operational excellence.

Company Information

Company

Selkirk Pharma

Location

827 W 1ST AVENUE

Spokane, Washington, United States

About

Selkirk Pharma, Inc., located in Spokane, Washington, was founded in 2018 by industry veterans with the vision to build the world’s most reliable manufacturer of injectable drug product. We are dedicated to quality and reliability while upholding a partnership philosophy to ensure drug safety and availability. With an experienced team averaging over 15 years in the industry, our professionals are passionate about optimizing fill and finish turn-around times and accelerating product release while never compromising patient care. At Selkirk Pharma, we treat your products with the highest commitment, ensuring we meet patient needs with integrity and excellence.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Selkirk Pharma's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.